Real Time Touch



new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)




Real Time Touch

Similar
Filing Names

Academisch Ziekenhuis Leiden
Academisch Ziekenhuis Leiden H o d n Lumc
Academisch Ziekenhuis Leiden H o d n
Academisch Ziekenhuis Leiden A u Leiden Uni Medical Ctr
Academisch Ziekenhuis Leiden A u Leiden University Medical Center
Academisch Ziekenhuis Leiden H o d n Lucm
Academisch Ziekenhuis Leiden also Acting Under The Name Of Leiden University Medical
Academisch Ziekenhuis Leiden H o d n Leids Universitair Medisch Centrum
  

Academisch Ziekenhuis Leiden patents

Recent patent applications related to Academisch Ziekenhuis Leiden. Academisch Ziekenhuis Leiden is listed as an Agent/Assignee. Note: Academisch Ziekenhuis Leiden may have other listings under different names/spellings. We're not affiliated with Academisch Ziekenhuis Leiden, we're just tracking patents.

ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "A" | Academisch Ziekenhuis Leiden-related inventors




Date Academisch Ziekenhuis Leiden patents (updated weekly) - BOOKMARK this page
09/07/17Genetic attenuation of plasmodium by b9 gene disruption
09/07/17A magnetic resonance apparatus comprising a plasma antenna
08/17/17Anti-carbamylated protein antibodies and the risk for arthritis
06/08/17Prohemostatic proteins for the treatment of bleeding
05/11/17In situ tissue engineering
04/20/17Methods and means for efficient skipping of exon 45 in duchenne muscular dystrophy pre-mrna
02/16/17Methods and means for efficient skipping of at least one of the following exons of the human duchenne muscular dystrophy gene: 43, 46, 50-53
12/08/16Modulation of exon recognition in pre-mrna by interfering with the secondary rna structure
10/20/16Means and methods for counteracting muscle disorders
09/22/16Tool head assembly and associated apparatus
09/01/16Modulation of exon recognition in pre-mrna by interfering with the secondary rna structure
06/16/16Modulation of exon recognition in pre-mrna by interfering with the secondary rna structure
04/28/16Differentiation and expansion of endothelial cells from pluripotent stem cells and the in vitro formation of vasculature like structures
02/25/16Method for efficient exon (44) skipping in duchenne muscular dystrophy and associated means
02/25/16Future cardiac event biomarkers
12/17/15Induction of exon skipping in eukaryotic cells
12/03/15Long peptides of 22-45 amino acid residues that induce and/or enhance antigen specific immune responses
11/12/15Induction of exon skipping in eukaryotic cells
11/05/15Genetic attenuation of plasmodium by b9 gene disruption
08/06/15Modulation of exon recognition in pre-mrna by interfering with the secondary rna structure
07/09/15Arterivirus protein and expression mechanisms
06/18/15Methods and means for efficient skipping of at least one of the following exons of the human duchenne muscular dystrophy gene: 43, 46, 50-53
03/19/15Modulation of exon recognition in pre-mrna by interfering with the secondary rna structure
12/25/14Modulation of exon recognition in pre-mrna by interfering with the secondary rna structure
12/04/14Modulation of exon recognition in pre-mrna by interfering with the secondary rna structure
09/18/14Modulation of exon recognition in pre-mrna by interfering with the secondary rna structure
07/31/14Modulation of exon recognition in pre-mrna by interfering with the secondary rna structure
03/21/13Modulation of exon recognition in pre-mrna by interfering with the secondary rna structure
03/08/12Method for efficient exon (44) skipping in duchenne muscular dystrophy and associated means
12/22/11Modulation of exon recognition in pre-mrna by interfering with the secondary rna structure
12/01/11Means and methods for counteracting muscle disorders
12/24/09Means and methods for modulating stem cell mobilization
09/10/09Induction of exon skipping in eukaryotic cells
09/01/16Malaria vaccination
03/10/16Miltefosin or perifosin for use in the treatment of ibd
08/05/10Intradermal hpv peptide vaccination
09/07/17Cd94/nkg2a and/or cd94/nkg2b antibody, vaccine combinations
08/17/17Anti-carbamylated protein antibodies and the risk for arthritis
08/10/17Antisense oligonucleotide directed removal of proteolytic cleavage sites, the hchwa-d mutation, and trinucleotide repeat expansions
06/22/17Antisense oligonucleotide directed removal of proteolytic cleavage sites from proteins
05/25/17Intradermal hpv peptide vaccination
11/17/16Prame derived peptides and immunogenic compositions comprising these
11/03/16Antimicrobial peptide and uses thereof
07/07/16Modulation of exon recognition in pre-mrna by interfering with the secondary rna structure
03/17/16Antimicrobial peptide
10/01/15Means and methods for modulating notch3 protein expression and/or the coding region of notch3; compositions and use thereof in the treatment of cadasil
02/26/15Hpv epitopes targeted by t cells infiltrating cervical malignancies for use in vaccines
01/08/15P53 peptide vaccine
11/27/14Prame derived peptides and immunogenic compositions comprising these
09/18/14Lipidomics of familial longevity
03/27/14Compounds and methods for altering activin receptor-like kinase signaling
02/06/14Antisense oligonucleotide directed removal of proteolytic cleavage sites, the hchwa-d mutation, and trinucleotide repeat expansions
08/01/13Antisense oligonucleotide directed removal of proteolytic cleavage sites from proteins
03/21/13Peptides, conjugates and increasing immunogenicity of a vaccine
10/25/12Methods and compositions for dysferlin exon-skipping
10/25/12Stable pharmaceutical formulations comprising lubiprostone
12/29/11Means and methods for modulating notch3 protein expression and/or the coding region of notch3; compositions and use thereof in the treatment of cadasil
12/22/11Delivery of a cd40 agonist to a tumor draining lymph node of a subject
06/16/11Peptidylarginine deiminase (pad) inhibitors
07/29/10Hpv epitopes targeted by t cells infiltrating cervical malignancies for use in vaccines
05/13/10Prame derived peptides and immunogenic compositions comprising these
07/07/16Recombinant aav-crumbs homologue composition and methods for treating lca-8 and progressive rp
02/23/17Vascular re-modelling
07/13/17R2r1/2 in diagnosis and therapy
03/06/14R2r1/2 in diagnosis and therapy
Patent Packs







ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Academisch Ziekenhuis Leiden in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Academisch Ziekenhuis Leiden with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###




';